Ventyx Biosciences, Inc. - Common stock, par value $0.0001 per share (VTYX) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2021 to Q4 2025

Type / Class
Equity / Common stock, par value $0.0001 per share
Symbol
VTYX on Nasdaq
Shares outstanding
71,085,776
Price per share
$9.03
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
43,853,431
Total reported value
$136,378,109
% of total 13F portfolios
0%
Share change
-559,691
Value change
-$468,450
Number of holders
109
Price from insider filings
$9.03
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Ventyx Biosciences, Inc. - Common stock, par value $0.0001 per share (VTYX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
NSV Investments I, L.P. 7.6% $6,836,036 5,425,425 Somasundaram Subramaniam 10 Mar 2025
Mohan Raju 6% 0% $39,622,524 +$48,060 4,387,682 +0.12% Raju Mohan 07 Jan 2026
Subramaniam Somu 5.8% $37,232,113 4,122,975 Subramaniam Somu 07 Jan 2026
NSV Partners III LP 5.7% $5,153,368 4,089,975 Subramaniam Somu 28 Mar 2025
Affinity Asset Advisors, LLC 5.7% $4,909,097 4,057,105 Affinity Healthcare Fund, LP 22 May 2025
VANGUARD GROUP INC 5.3% $11,725,822 3,769,997 The Vanguard Group 30 Sep 2025
Point72 Asset Management, L.P. 4.5% -48% $9,981,996 -$8,351,669 3,209,645 -46% Point72 Asset Management, L.P. 30 Sep 2025
Sio Capital Management, LLC 3.6% -35% $3,254,145 -$1,844,819 2,582,655 -36% Sio Capital Management, LLC 31 Mar 2025
CITADEL ADVISORS LLC 2% $1,776,097 1,409,601 Kenneth Griffin 31 Mar 2025
BlackRock, Inc. 1.9% $2,891,112 1,350,987 BlackRock, Inc. 30 Jun 2025
BANK OF AMERICA CORP /DE/ 1.4% -73% $1,280,978 -$4,535,858 1,016,649 -78% BANK OF AMERICA CORP /DE/ 31 Mar 2025
Flynn James E 0.76% $673,769 534,737 Deerfield Mgmt, L.P. 31 Dec 2024

As of 30 Sep 2025, 109 institutional investors reported holding 43,853,431 shares of Ventyx Biosciences, Inc. - Common stock, par value $0.0001 per share (VTYX). This represents 62% of the company’s total 71,085,776 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Ventyx Biosciences, Inc. - Common stock, par value $0.0001 per share (VTYX) together control 50% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Affinity Asset Advisors, LLC 5.5% 3,924,415 -13% 1.1% $12,204,931
VANGUARD GROUP INC 5.3% 3,769,997 +19% 0% $11,724,691
Point72 Asset Management, L.P. 4.5% 3,209,645 -46% 0.02% $9,981,996
TANG CAPITAL MANAGEMENT LLC 4.4% 3,100,000 0% 0.37% $9,641,000
MARSHALL WACE, LLP 3.3% 2,316,275 -3.4% 0.01% $7,203,615
Vestal Point Capital, LP 2.9% 2,050,000 +2.5% 0.29% $6,375,500
CITADEL ADVISORS LLC 2.6% 1,879,989 +6.5% 0% $5,846,766
MILLENNIUM MANAGEMENT LLC 2.3% 1,651,794 +18% 0% $5,137,079
Ikarian Capital, LLC 1.8% 1,309,604 +35% 0.93% $4,072,869
BlackRock, Inc. 1.7% 1,183,240 -14% 0% $3,679,877
SECTORAL ASSET MANAGEMENT INC 1.6% 1,107,267 +19% 2.1% $3,443,600
Redmile Group, LLC 1.5% 1,073,386 -3.7% 0.32% $3,338,230
Connor, Clark & Lunn Investment Management Ltd. 1.5% 1,059,823 +12% 0.01% $3,296,050
BAKER BROS. ADVISORS LP 1.4% 1,023,130 0.02% $3,181,934
683 Capital Management, LLC 1.4% 1,000,000 0.28% $3,110,000
Sio Capital Management, LLC 1.2% 829,178 -37% 0.65% $2,578,744
JPMORGAN CHASE & CO 1.1% 748,088 +63% 0% $2,326,554
GEODE CAPITAL MANAGEMENT, LLC 1% 728,720 +2.4% 0% $2,267,093
ACADIAN ASSET MANAGEMENT LLC 0.99% 703,800 +14% 0% $2,184,000
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.96% 679,978 +40% 0% $2,114,732
BANK OF AMERICA CORP /DE/ 0.74% 529,249 -37% 0% $1,645,965
UBS Group AG 0.74% 527,292 +43% 0% $1,639,878
D. E. Shaw & Co., Inc. 0.74% 522,688 +968% 0% $1,625,560
SPHERA FUNDS MANAGEMENT LTD. 0.62% 440,114 -21% 0.32% $1,368,755
TWO SIGMA INVESTMENTS, LP 0.61% 436,082 0% $1,356,215

Institutional Holders of Ventyx Biosciences, Inc. - Common stock, par value $0.0001 per share (VTYX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 2,261 $20,417 -$24,554 $9.03 6
2025 Q3 43,853,431 $136,378,109 -$468,450 $3.11 109
2025 Q2 44,427,101 $95,066,026 +$2,059,789 $2.14 112
2025 Q1 44,413,797 $51,071,272 -$13,704,510 $1.15 116
2024 Q4 54,449,340 $119,241,531 +$4,099,056 $2.19 122
2024 Q3 52,481,458 $114,411,828 -$11,847,686 $2.18 115
2024 Q2 57,252,817 $132,254,360 -$36,320,827 $2.31 114
2024 Q1 58,990,812 $323,851,608 +$111,976,682 $5.50 122
2023 Q4 43,247,569 $106,821,389 -$553,553,365 $2.47 118
2023 Q3 54,583,406 $1,895,690,669 +$62,410,449 $34.73 137
2023 Q2 52,627,413 $1,726,219,124 +$92,758,720 $32.80 146
2023 Q1 49,748,691 $1,666,552,448 +$243,592,644 $33.50 143
2022 Q4 42,351,969 $1,388,715,670 +$101,470,239 $32.79 122
2022 Q3 39,299,041 $1,371,090,008 +$167,335,144 $34.91 104
2022 Q2 34,630,744 $423,528,800 +$16,981,526 $12.23 58
2022 Q1 33,233,009 $448,438,000 +$21,644,387 $13.57 53
2021 Q4 30,695,789 $601,183,000 +$601,183,000 $19.86 45